Influence of the Assays of Endogenous Colony Formation and Serum Erythropoietin on the Diagnosis of Polycythemia Vera and Essential Thrombocythemia

ABSTRACT

Formation of endogenous erythroid colonies (EECs) or endogenous megakaryocytic colonies (EMCs) is a hallmark of myeloproliferative disorders (MPDs). The diagnostic value of EEC for polycythemia vera (PV) using standardized media has been demonstrated, and has led clinicians to consider EEC as a major diagnostic criterion in the WHO classification. The interest of EEC currently needs to be considered taking into account recent data about V617F JAK2 mutation in MPD. In particular, EECs and EMCs should be helpful for the diagnostic and the vascular risk evaluation of essential thrombocythemia (ET) and for mutation negative patients. A low serum erythropoietin (EPO) level is a consistent finding in PV. Recent studies have shown that commercial serum EPO assays provided a reliable, accurate, and low-cost criterion for the diagnosis of a significant proportion of PV. It suggests that diagnostic algorithms integrating serum EPO level could be elaborated. The diagnostic value of EPO assay for thrombocytosis has not been proved, but some data suggest a predictive value of low EPO levels for thrombosis in ET.

KEYWORDS

Erythropoietin - endogenous erythroid colonies (EECs) - endogenous megakaryocytic colonies (EMCs) - polycythemias - thrombocytosis

REFERENCES

• 1 Prchal J F, Axelrad A A. Bone marrow responses in polycythemia vera.  N Engl J Med. 1974;  290 1382 , (lett)
• 2 James C, Ugo V, Le Couedic J P et al.. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.  Nature. 2005;  434 1144-1148
• 3 Kralovics R, Passamonti F, Buser A S et al.. A gain-of-function mutation of JAK2 in myeloproliferative disorders.  N Engl J Med. 2005;  352 1779-1790
• 4 Baxter E J, Scott L M, Campbell P J et al.. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Cancer Genome Project.  Lancet. 2005;  365 1054-1061
• 5 Westwood N B, Pearson T C. Diagnostic applications of haemopoietic progenitor culture techniques in polycythemias and thrombocytaemias.  Leuk Lymphoma. 1996;  22 95-103
• 6 Casadevall N, Vainchencker W, Lacombe C et al.. Erythroid progenitors in polycythemia vera: demonstration of their hypersensitivity to erythropoietin using serum-free cultures.  Blood. 1982;  59 447-451
• 7 Eaves C J, Eaves A C. Erythropoietin dose-response curves for three classes of erythroid progenitors in normal human marrow and with patients polycythemia vera.  Blood. 1978;  52 1196-1210
• 8 Eridani S, Dudley J M, Sawyer B M et al.. Erythropoietic colonies in a serum-free system: results in primary proliferative polycythaemia and thrombocythaemia.  Br J Haematol. 1987;  67 387-391
• 9 Dobo I, Mossuz P, Campos L et al.. Comparison of four serum-free, cytokine-free media for analysis of endogenous erythroid colony growth in polycythemia vera and essential thrombocythemia.  Hematol J. 2001;  2 396-403
• 10 Dobo I, Boiret N, Lippert E et al.. A standardized endogenous megakaryocytic/erythroid (EMC/EEC) colony assay for the diagnosis of essential thrombocythemia.  Haematologica. 2004;  89 1207-1212
• 11 Dobo I, Pineau D, Zandecki M et al.. Endogenous erythroid and megakaryocytic colony formation in serum-free, cytokine-free collagen gels.  J Hematother Stem Cell Res. 1999;  8 601-607
• 12 Juvonen E, Ikkala E, Oksanen K et al.. Megakaryocyte and erythroid colony formation in essential thrombocythemia and reactive thrombocytosis: diagnostic value and correlation to complications.  Br J Haematol. 1993;  83 192-197
• 13 Florenza L, Besses C, Woessner S et al.. Endogenous megakaryocyte and erythroid colony formation from blood in essential thrombocythemia.  Leukemia. 1995;  2 271-273
• 14 Rolovic Z, Basara N, Gotic M et al.. The determination of endogenous megakaryocytic colony formation is an unequivocal test for discrimination between essential thrombocythemia and reactive thrombocytosis.  Br J Haematol. 1995;  90 326-331
• 15 Mi J Q, Blanc-Jouvan F, Wang J et al.. Endogenous megakaryocytic colony formation and thrombopoietin sensitivity of megakaryocytic progenitor cells are useful to distinguish between essential thrombocythemia and reactive thrombocytosis.  J Hematother Stem Cell Res. 2001;  10 405-409
• 16 Griesshammer M, Klippel S, Strunck E et al.. PRV-1 mRNA expression discriminates two types of essential thrombocythemia.  Ann Hematol. 2004;  83 364-370
• 17 Goerttler P S, Steimle C, Marz E et al.. The Jak2V617F mutation, PRV-1 overexpression, and EEC formation define a similar cohort of MPD patients.  Blood. 2005;  106 2862-2864
• 18 Campbell P J, Scott L M, Buck G et al.. Definition of subtypes of essential thrombocythemia and relation to polycythemia vera based on JAK2V617F mutation status: a prospective study.  Lancet. 2005;  366 1945-1953
• 19 Pearson T C. Evaluation of diagnostic criteria in polycythemia vera.  Semin Hematol. 2001;  38 21-24
• 20 Reid C D, Fidler J, Kirk A. Endogenous erythroid clones (EEC) in polycythaemia and their relationship to diagnosis and the response to treatment.  Br J Haematol. 1988;  68 395-400
• 21 Shih L Y, Lee C T, Ou Y C. Prediction of clinical course in patients with idiopathic erythrocytosis by endogenous erythroid colony assay but not by serum erythropoietin levels.  Exp Hematol. 1997;  25 288-292
• 22 Lemoine F, Najman A, Baillou C et al.. Prospective study of the value of bone marrow erythroid progenitor cultures in polycythemia.  Blood. 1986;  68 996-1002
• 23 Kendall R G. Erythropoietin.  Clin Lab Haematol. 2001;  2 71-80
• 24 Tefferi A. Polycythemia vera: a comprehensive review and clinical recommendations.  Mayo Clin Proc. 2003;  78 174-194
• 25 Gordeuk V R, Stockton D W, Prchal J T. Congenital polycythemias/erythrocytoses.  Haematologica. 2005;  90 109-116
• 26 Erslev A J, Caro J. Pure erythrocytosis classified according to erythropoietin titers.  Am J Med. 1984;  76 57-61
• 27 Birgegard G, Wide L. Serum erythropoietin in the diagnosis of polycythaemia and after phlebotomy treatment.  Br J Haematol. 1992;  81 603-606
• 28 Remacha A F, Montserrat I, Santamaria A et al.. Serum erythropoietin in the diagnosis of polycythemia vera. A follow-up study.  Haematologica. 1997;  82 406-410
• 29 Carneskog J, Kutti J, Wadenvik H et al.. Plasma erythropoietin by high-detectability immunoradiometric assay in untreated and treated patients with polycythaemia vera and essential thrombocythaemia.  Eur J Haematol. 1998;  60 278-282
• 30 Messinezy M, Nigel B, Westwood N B et al.. Serum erythropoietin values in erythrocytoses and in primary thrombocythaemia.  Br J Haematol. 2002;  117 47-53
• 31 Mossuz P, Girodon F, Donnard M et al.. Diagnostic value of serum erythropoietin level in patients with absolute erythrocytosis.  Haematologica. 2004;  89 1194-1198
• 32 Spivak J L. Polycythemia vera: myths, mechanisms, and management.  Blood. 2002;  100 4272-4290
• 33 Casadevall N. Determination of serum erythropoietin. Its value in the differential diagnosis of polycythemias.  Nouv Rev Fr Hematol. 1994;  36 173-176
• 34 Andreasson B, Carneskog J, Lindstedt G et al.. Plasma erythropoietin concentrations in polycythaemia vera with special reference to myelosuppressive therapy.  Leuk Lymphoma. 2000;  37 189-195
• 35 Mossuz P, Girodon F, Hermouet S et al.. Serum erythropoietin determination by chemiluminescent immunometry: an accurate diagnostic test for absolute erythrocytosis.  Clin Chem. 2005;  51 1018-1021
• 36 Andreasson B, Lindstedt G, Kutti J. plasma erythropoietin in essential thrombocythemia: at diagnosis and in response to myelosuppressive treatment.  Leuk Lymphoma. 2000;  38 113-120
• 37 Griesshammer M, Kubanek B, Beneke H et al.. Serum erythropoietin and thrombopoietin levels in patients with essential thrombocythaemia.  Leuk Lymphoma. 2000;  36 533-538
• 38 Girodon F, Hermouet S, Dobo I et al.. Serum erythropoietin values and endogenous erythroid colony growth in erythrocytoses and essential thrombocythaemia.  Br J Haematol. 2003;  120 171 , (lett)
• 39 Andreasson B, Lindstedt G, Stockelberg D et al.. The relation between plasma thrombopoietin and erythropoietin concentrations in polycythemia vera and essential thrombocythemia.  Leuk Lymphoma. 2001;  41 579-584
• 40 Johansson P, Andreasson B, Safai-Kutti S et al.. The presence of a significant association between elevated PRV-1 mRNA expression and low plasma erythropoietin concentration in essential thrombocythaemia.  Eur J Haematol. 2003;  70 358-362
• 41 Andreasson B, Harrison C, Lindstedt G et al.. Monoclonal myelopoiesis and subnormal erythropoietin concentration are independent risk factors for thromboembolic complications in essential thrombocythemia.  Blood. 2003;  101 783-784
• 42 Tefferi A, Sirhan S, Lasho T L et al.. Concomitant neutrophil JAK2 mutation screening and PRV-1 expression analysis in myeloproliferative disorders and secondary polycythaemia.  Br J Haematol. 2005;  131 166-171